nach oben

Erschienen in:

03.05.2016 | Apoplex | Zertifizierte Fortbildung

Komorbidität neurologischer Erkrankungen

Migräne und ischämischer Schlaganfall

verfasst von: Dr. Caroline Freilinger, Victoria Schubert, Dr. med. Eva Auffenberg, PD Dr. med. Tobias Freilinger

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Migräne ist ein Risikofaktor für klinisch manifeste Schlaganfälle, echte migränöse Infarkte sind aber selten. Sie kommt in relevanter Weise als „stroke mimic“ infrage, ebenso können ischämische Schlaganfälle symptomatische Migräneattacken triggern. Der pathophysiologische Zusammenhang von Migräne und zerebraler Ischämie ist bisher nur unvollständig verstanden. An Befunde einer reduzierten Ischämietoleranz bei Migränepatienten und erste Daten zu einer gemeinsamen genetischen Basis von Migräne und Schlaganfall knüpft sich die Hoffnung einer weiteren Entschlüsselung der biologischen Basis dieser Komorbidität.

The International Classification of Headache Disorders, 3rd edition (beta version). Headache Classification Committee of the International Headache Society (IHS). Cephalalgia 2013;33(9):629-808.

Freilinger T, Dichgans M. Migräne, Schlaganfall und „white matter lesions“. Akt Neurol 2011; 38(08): 436–441.CrossRef

Mawet J, Kurth T, Ayata C. Migraine and stroke: in search of shared mechanisms. Cephalalgia 2015;35(2):165–81.CrossRefPubMed

Feìreì C. Note sur un cas de migraine ophtalmique aÌ acceÌs reìpeìteìs suivis de mort. Rev Med (Paris) 1883; 3: 194–201.

Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005; 4: 533–542.CrossRefPubMed

Li L, Schulz UG, Kuker W, Rothwell PM; Oxford Vascular Study. Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology 2015;85(17):1444–51. doi: 10.1212/WNL.0000000000002059. Epub 2015 Sep 30.CrossRefPubMedPubMedCentral

Laurell K, Artto V, Bendtsen L et al. Migrainous infarction: a Nordic multicenter study. Eur J Neurol 2011. 18(10):1220–6.CrossRefPubMed

Frigerio R, Santoro P, Ferrarese C, Agostoni E. Migrainous cerebral infarction: case reports. Neurol Sci 2004; 25(suppl 3):S300–S301.CrossRefPubMed

Wolf ME, Szabo K, Griebe M et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011; 76: 1911–1917.CrossRefPubMed

10.

Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117 (Pt 1): 199–210CrossRefPubMed

11.

Nozari A, Dilekoz E, Sukhotinsky I et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010; 67: 221–229CrossRefPubMedPubMedCentral

12.

Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996 Apr;119 ( Pt 2):355–61.CrossRefPubMed

13.

Freilinger T. Genetics of primary headache syndromes. Bundesgesundheitsblatt 2014 Aug;57(8):919–27. doi: 10.1007/s00103-014-1998-0.CrossRef

14.

van den Maagdenberg AMJM, Pietrobon D, Pizzo-russo T et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004; 41(5):701–710.CrossRefPubMed

15.

van den Maagdenberg AMJM, Pizzorusso T, Kaja S et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca v2.1 S218L mice. Ann Neurol 2010; 67(1):85–98.CrossRefPubMed

16.

Leo L, Gherardini L, Barone V et al. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 2011; 7(6):e1002129–9.CrossRefPubMedPubMedCentral

17.

Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol 2015;14(1):65–80. doi: 10.1016/S1474-4422(14)70220-0.CrossRefPubMed

18.

Floery D, Vosko MR, Fellner FA, Fellner C, Ginthoer C, Gruber F, Ransmayr G, Doerfler A, Uder M, Bradley WG. Acute-onset migrainous aura mimicking acute stroke: MR perfusion imaging features. AJNR Am J Neuroradiol. 2012 Sep;33(8):1546–52. doi: 10.3174/ajnr.A3020. Epub 2012 Apr 19.CrossRefPubMed

19.

Olesen J, Friberg L, Olsen TS, Andersen AR, Lassen NA, Hansen PE, Karle A. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993 Feb;116 (Pt 1):187–202.CrossRefPubMed

20.

Etminan M, Takkouche B, Isorna FC et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Bmj 2005; 330: 63.CrossRefPubMedPubMedCentral

21.

Schurks M, Rist PM, Bigal ME et al. Migraine and cardiovascular di- sease: systematic review and meta-analysis. Bmj 2009; 339: b3914.CrossRefPubMedPubMedCentral

22.

Spector JT, Kahn SR, Jones MR et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123: 612–624.CrossRefPubMedPubMedCentral

23.

Kurth T, Slomke MA, Kase CS et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005; 64: 1020–1026.CrossRefPubMed

24.

Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004 Feb 24;62(4):563–8.CrossRefPubMed

25.

MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women study. Stroke 2007;38: 2438–2445.CrossRefPubMed

26.

Schwaag S, Nabavi DG, Frese A, Husstedt IW, Evers S. The association between migraine and juvenile stroke: a case-control study. Headache 2003;43:90–95.CrossRefPubMed

27.

Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009;73:581–588.CrossRefPubMedPubMedCentral

28.

Donaghy M, Chang CL, Poulter N; European Collaborators of The World Health Organisation Collaborative Study of Cardiovascular D, Steroid Hormone C. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002;73:747–750.CrossRefPubMedPubMedCentral

29.

Kurth T, Diener HC, Buring JE. Migraine and cardiovascular disease in women and the role of aspirin: Subgroup analyses in the Women’s Health Study. Cephalalgia 2011; 31: 1106–1115.CrossRefPubMedPubMedCentral

30.

Bigal ME, Kurth T, Santanello N et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010; 74: 628–635CrossRefPubMedPubMedCentral

31.

Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. Jama 2004; 291: 427–434.CrossRefPubMed

32.

Kruit MC, van Buchem MA, Launer LJ et al. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 2010; 30: 129–136.PubMedPubMedCentral

33.

Hamedani AG, Rose KM, Peterlin BL, Mosley TH, Coker LH, Jack CR, Knopman DS, Alonso A, Gottesman RF. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013; 81(15):1308–13.CrossRefPubMedPubMedCentral

34.

Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol. 2004 Sep;61(9):1366–8.CrossRefPubMed

35.

Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 2013; 81(14):1260–8. doi: 10.1212/WNL.0b013e3182a6cb32.CrossRefPubMedPubMedCentral

36.

Kurth T, Mohamed S, Maillard P et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. Bmj 2011; 342: c7357.CrossRefPubMedPubMedCentral

37.

Kruit MC, Launer LJ, Ferrari MD et al. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128: 2068–2077.CrossRefPubMed

38.

Scher AI, Gudmundsson LS, Sigurdsson S et al. Migraine headache in middle age and late-life brain infarcts. Jama 2009; 301: 2563–2570.CrossRefPubMedPubMedCentral

39.

Harno H, Hirvonen T, Kaunisto MA et al. Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology 2003; 61: 1748–1752.CrossRefPubMed

40.

Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC. Structural brain changes in migraine. JAMA. 2012 Nov 14;308(18):1889–97. doi: 10.1001/jama.2012.14276.CrossRefPubMedPubMedCentral

41.

Bigal ME, Kurth T, Hu H et al. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009; 72: 1864–1871CrossRefPubMedPubMedCentral

42.

Rist PM, Diener H-C, Kurth T, et al. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 2011; 31(8): 886–896.CrossRefPubMedPubMedCentral

43.

Metso TM, Tatlisumak T, Debette S, et al. Migraine in cervical artery dissection and ischemic stroke patients. Neurology 2012; 78(16): 1221–1228.CrossRefPubMed

44.

Mawet J, Boukobza M, Franc J, Sarov M, Arnold M, Bousser MG, Ducros A. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology 2013;81(9):821–4.CrossRefPubMed

45.

Debette S, Kamatani Y, Metso TM, et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet 2015; 47(1): 78–83.CrossRefPubMed

46.

Freilinger T, Anttila V, de Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012; 44(7): 777–782.CrossRefPubMedPubMedCentral

47.

Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007; 68(19):1563–70.CrossRefPubMed

48.

Lee ST, Chu K, Jung KH et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70: 1510–1517CrossRefPubMed

49.

Liman TG, Bachelier-Walenta K, Neeb L, Rosinski J, Reuter U, Böhm M, Endres M. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia. 2015; 35(2):88–94. doi: 10.1177/0333102414529671.CrossRefPubMed

50.

Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008; 28: 531–540.CrossRefPubMed

51.

Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117(11):1397–404. doi: 10.1161/CIRCULATIONAHA.107.727271. Epub 2008 Mar 3. Erratum in: Circulation. 2009 Sep 1;120(9):e71-2.CrossRefPubMed

52.

Davis D, Gregson J, Willeit P, Stephan B, Al-Shahi Salman R, Brayne C. Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology. 2013;40(1):56–67. doi: 10.1159/000341924.CrossRefPubMed

53.

Strong AJ, Anderson PJ, Watts HR, et al. Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain 2007; 130(Pt 4): 995–1008.PubMed

54.

Shin HK, Dunn AK, Jones PB, et al. Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 2006; 26(8): 1018–1030.CrossRefPubMed

55.

Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischae- mic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006; 129(Pt 12): 3224–3237.CrossRefPubMed

56.

Lückl J, Dreier JP, Szabados T, et al. Peri-infarct flow transients predict outcome in rat focal brain ischemia. Neuroscience 2012; 226: 197–207.CrossRefPubMedPubMedCentral

57.

Eikermann-Haerter K, Lee JH, Yuzawa I, et al. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 2012; 125(2): 335–345.CrossRefPubMedPubMedCentral

58.

Mawet J, Eikermann-Haerter K, Park KY, Helenius J, Daneshmand A, Pearlman L, Avery R, Negro A, Velioglu M, Arsava EM, Ay H, Ayata C. Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study. Neurology 2015;85(22):1945–9.CrossRefPubMed

59.

GE Tietjen, S Sacco, Migraine makes the stroke grow faster? Neurology. 2015 Dec 1;85 22 1920–1

60.

Malik R, Winsvold B, Auffenberg E, Dichgans M, Freilinger T. The migraine-stroke connection: A genetic perspective. Cephalalgia 2015. pii: 0333102415621055.

61.

Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993; 3(3): 256–259.CrossRefPubMed

62.

Chabriat H, Joutel A, Dichgans M, et al. CADASIL. Lancet Neurol 2009; 8(7): 643–653.CrossRefPubMed

63.

Vahedi K, Chabriat H, Levy C, et al. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004; 61(8): 1237–1240.CrossRefPubMed

64.

Guey S, Mawet J, Hervé D, Duering M, Godin O, Jouvent E, Opherk C, Alili N, Dichgans M, Chabriat H. Prevalence and characteristics of migraine in CADASIL. Cephalalgia 2015; pii: 0333102415620909.

65.

Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44(5): 731–739.CrossRefPubMed

66.

Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004; 127(Pt 11): 2533–2539.CrossRefPubMed

67.

Jouvent E, Mangin J-F, Herve D, et al. Cortical folding influences migraine aura symptoms in CADASIL. J Neurol Neurosurg Psychiatry 2012; 83(2): 213–216.CrossRefPubMed

68.

Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 2010; 42(10): 869–873.CrossRefPubMedPubMedCentral

69.

ChasmanDI, Schürks M, Anttila V, etal. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 2011; 43(7): 695–698.CrossRef

70.

Anttila V, Winsvold BS, Gormley P, et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 2013; 45(8): 912–917.CrossRefPubMedPubMedCentral

71.

Eising E, de Vries B, Ferrari MD, Terwindt GM, van den Maagdenberg AM. Pearls and pitfalls in genetic studies of migraine. Cephalalgia 2013; 33(8):614–25. doi: 10.1177/0333102413484988.CrossRefPubMed

72.

Malik R, Freilinger T, Winsvold BS, et al. Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology 2015; 84(21): 2132–2145.CrossRefPubMedPubMedCentral

73.

Schürks M, Buring JE, Ridker PM, et al. Genetic deter- minants of cardiovascular events among women with migraine: a genome-wide association study. PLoS ONE 2011; 6(7): e22106.CrossRefPubMedPubMedCentral

74.

Deutsche Gesellschaft für Neurologie, Therapie der Migräne. AWMF-Registriernummer: 030 – 057.

Titel: Komorbidität neurologischer Erkrankungen
Migräne und ischämischer Schlaganfall
verfasst von: Dr. Caroline Freilinger
Victoria Schubert
Dr. med. Eva Auffenberg
PD Dr. med. Tobias Freilinger
Publikationsdatum: 03.05.2016
Verlag: Springer Medizin
Schlagwörter: Apoplex
Migräne
Aura
CADASIL
Erschienen in: DNP – Die Neurologie & Psychiatrie / Ausgabe 5/2016
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI: https://doi.org/10.1007/s15202-016-1046-z

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

Psychologische Intervention plus medikamentöse Unterstützung

Gesunder Mittagsschlaf? — Das hängt vom Alter und von der Dauer ab

Neue GOÄ kommt wohl nicht mehr vor der Bundestagswahl

Jährlicher Rundumblick in zwei Tagen

MS: Vielfalt der Möglichkeiten nutzen

App für Dystoniepatienten